Literature DB >> 12579624

Frequency-volume chart: the minimum number of days required to obtain reliable results.

Erik Schick1, Martine Jolivet-Tremblay, Charles Dupont, Pierre E Bertrand, Jocelyne Tessier.   

Abstract

AIMS: There is wide variation in the number of days necessary to maintain a diary and still furnish reliable data on which to base a sound clinical assessment. Estimates range from 1 day to 2 weeks, 7 days probably being the criterion standard. The goal of this retrospective study was to evaluate how much the 7-day period could be shortened without compromising the reliability of data.
METHODS: Various lengths of frequency-volume (FV) charts (from 1 day to 6 days) were compared with the standard 7-day charts on 14 FV parameters.
RESULTS: Overall results show that a 4-day dairy is nearly identical to the 7-day chart (most r > or = 0.95). Results of the 1-, 2-, and 3-day charts were frequently different statistically from the 7-day chart, whereas comparison of the 4-day chart with the 7-day chart showed no statistically significant differences. In addition, results of 4-day FV charts from a new control cohort showed no significant differences from the 7-day charts of the main cohort.
CONCLUSIONS: In conclusion, our study indicates that the 4-day chart is as reliable as the 7-day chart. This reduction in the length of time, although easier for the patients, does not compromise the diagnostic value of the FV charts. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12579624     DOI: 10.1002/nau.10079

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  12 in total

Review 1.  Pharmacological management of women with mixed urinary incontinence.

Authors:  Hashim Hashim; Paul Abrams
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Reliability of the 24-h sensation-related bladder diary in women with urinary incontinence.

Authors:  Irina Naoemova; Stefan De Wachter; Floris L Wuyts; Jean-Jacques Wyndaele
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-01-31

Review 3.  Factors influencing efficacy endpoints in clinical trials for new oral medicinal treatments for overactive bladder: a systematic literature review and meta-analysis.

Authors:  Shingo Iino; Masayuki Kaneko; Mamoru Narukawa
Journal:  Int Urol Nephrol       Date:  2018-04-12       Impact factor: 2.370

4.  Dual growth factor-loaded in situ gel-forming bulking agent: passive and bioactive effects for the treatment of urinary incontinence.

Authors:  Se Heang Oh; Jin Woo Bae; Jun Goo Kang; In Gul Kim; Joo Young Son; Ji Youl Lee; Ki Dong Park; Jin Ho Lee
Journal:  J Mater Sci Mater Med       Date:  2015-01-13       Impact factor: 3.896

Review 5.  Practical evaluation of post-prostatectomy incontinence.

Authors:  Sidney B Radomski
Journal:  Can Urol Assoc J       Date:  2013-09       Impact factor: 1.862

Review 6.  Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations.

Authors:  Hashim Hashim; Paul Abrams
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Medical management of overactive bladder.

Authors:  Sarvpreet S Ubee; Ramaswamy Manikandan; Gurpreet Singh
Journal:  Indian J Urol       Date:  2010-04

8.  [Overactive bladder--which diagnosis investigations are necessary before initiating primary treatment?].

Authors:  B Schönberger
Journal:  Urologe A       Date:  2003-04-25       Impact factor: 0.639

9.  Associations between subjective overactive bladder symptoms and objective parameters on bladder diary and filling cystometry.

Authors:  N M P Daan; K J Schweitzer; C H van der Vaart
Journal:  Int Urogynecol J       Date:  2012-04-28       Impact factor: 2.894

10.  Efficacy of physiotherapy for urinary incontinence following prostate cancer surgery.

Authors:  Elżbieta Rajkowska-Labon; Stanisław Bakuła; Marek Kucharzewski; Zbigniew Sliwiński
Journal:  Biomed Res Int       Date:  2014-04-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.